Engineers Gate Manager’s Enanta Pharmaceuticals ENTA Stock Holding History

Engineers Gate Manager’s Portfolio ENTA Stock Details ENTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$191K	Sell	13,080 -3,933	-23%	-$52.9K	﹤0.01%	1970
2026 Q1	$215K	Buy	+17,013	New	+$228K	﹤0.01%	1878
2025 Q1	–	Sell	-10,701	Closed	-$61.5K	–	2266
2024 Q4	$61.5K	Buy	+10,701	New	+$103K	﹤0.01%	2059
2024 Q1	–	Sell	-27,895	Closed	-$262K	–	2013
2023 Q4	$262K	Buy	+27,895	New	+$260K	0.01%	1525
2023 Q3	–	Sell	-10,178	Closed	-$218K	–	1873
2023 Q2	$218K	Buy	+10,178	New	+$300K	0.01%	1440
2020 Q3	–	Sell	-4,460	Closed	-$224K	–	1754
2020 Q2	$224K	Buy	+4,460	New	+$231K	0.01%	1386
2020 Q1	–	Sell	-7,520	Closed	-$465K	–	1665
2019 Q4	$465K	Buy	7,520 +1,263	+20%	+$78.3K	0.02%	1022
2019 Q3	$376K	Buy	6,257 +3,217	+106%	+$239K	0.02%	901
2019 Q2	$256K	Buy	+3,040	New	+$273K	0.01%	914
2015 Q3	–	Sell	-7,367	Closed	-$331K	–	733
2015 Q2	$331K	Buy	+7,367	New	+$287K	0.03%	771

Other funds holding ENTA

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KAM

Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SSC

Spruce Street Capital New York $510M AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Engineers Gate Manager's ENTA Position: Q2 2026 in Review

Engineers Gate Manager reduced its Enanta Pharmaceuticals (ENTA) stake by 23% in Q2 2026, selling an estimated $52.9K and leaving 13,080 shares worth $191K. The position accounts for ﹤0.01% of the portfolio, ranked #1970.

Engineers Gate Manager first reported a position in ENTA in Q2 2015 and has held it in 10 quarters since. The position peaked at $465K in Q4 2019. 123 funds tracked by Wall St. Rank hold ENTA as of Q2 2026.

Engineers Gate Manager held 13,080 shares of Enanta Pharmaceuticals worth $191K as of Q2 2026.
Engineers Gate Manager sold 3,933 Enanta Pharmaceuticals shares in Q2 2026, an estimated $52.9K.
Enanta Pharmaceuticals made up ﹤0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1970 holding.
Engineers Gate Manager first reported a position in Enanta Pharmaceuticals in Q2 2015 and has held it in 10 quarters since.
Engineers Gate Manager's Enanta Pharmaceuticals position peaked at $465K in Q4 2019.
123 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.